-
Something wrong with this record ?
Understanding the crisis in harm reduction funding in Central and Eastern Europe
M. Miovský, S. Miklíková, V. Mravčík, JP. Grund, T. Černíková
Language English Country Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
BioMedCentral
from 2004-12-01
BioMedCentral Open Access
from 2004
Directory of Open Access Journals
from 2004
Free Medical Journals
from 2004
PubMed Central
from 2004
Europe PubMed Central
from 2004
ProQuest Central
from 2009-01-01
Open Access Digital Library
from 2004-03-01
Open Access Digital Library
from 2004-01-01
Open Access Digital Library
from 2004-01-01
Medline Complete (EBSCOhost)
from 2012-01-01
Health & Medicine (ProQuest)
from 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2004
Springer Nature OA/Free Journals
from 2004-12-01
- MeSH
- Humans MeSH
- Substance-Related Disorders * MeSH
- Delivery of Health Care MeSH
- Harm Reduction * MeSH
- Public Policy MeSH
- Health Services MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
BACKGROUND: The harm reduction (HR) approach to injecting drug use was rapidly adopted in Central Europe following the fall of the Iron Curtain. The associated social and economic transformation had significant consequences for drug policies in the region. A large number of emerging services have been dependent on funding from a wide range of national and/or local funding programmes, which continue to be unstable, and closely associated with political decisions and insufficient institution building. A sharp distinction is made between health and social services, often without regard to client input. The main objective of the paper is to identify the causes of the funding problems currently faced by HR services in the context of their history of institution building which represents a major threat to the future of HR services in the region. METHODS: Qualitative content analysis of documents was conducted in the development of two case studies of the Czech and Slovak Republics. The body of documentation under study comprised policy documents, including National Drug Strategies, Action Plans, ministerial documents, and official budgets and financial schedules, as well as documents from the grey literature and expert opinions. RESULTS: The insufficient investments in finalising the process of the institution building of HR services have resulted in a direct threat to their sustainability. An unbalanced inclination to the institutionalisation of HR within the domain of social services has led to a misperception of their integrity, as well as to their funding and long-term sustainability being endangered. In addition, this tendency has had a negative impact on the process of the institutionalisation of HR within the system of healthcare. CONCLUSION: The case study revealed a lack of systemic grounding of HR services as interdisciplinary health-social services. The aftermath of the financial crisis in 2008 fully revealed the limitations of the funding system established ad hoc in the 1990s, which remains present until today, together with all its weak points. The entire situation is responsible for the dangerous erosion of the interpretation of the concept of harm reduction, which is supported by various stereotypes and false, or ideological, interpretations of the concept.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22004833
- 003
- CZ-PrNML
- 005
- 20220127144933.0
- 007
- ta
- 008
- 220113s2020 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s12954-020-00428-6 $2 doi
- 035 __
- $a (PubMed)33092597
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Miovský, Michal $u Department of Addictology, First Faculty of Medicine, and General University Hospital in Prague, Charles University, Prague, Czech Republic
- 245 10
- $a Understanding the crisis in harm reduction funding in Central and Eastern Europe / $c M. Miovský, S. Miklíková, V. Mravčík, JP. Grund, T. Černíková
- 520 9_
- $a BACKGROUND: The harm reduction (HR) approach to injecting drug use was rapidly adopted in Central Europe following the fall of the Iron Curtain. The associated social and economic transformation had significant consequences for drug policies in the region. A large number of emerging services have been dependent on funding from a wide range of national and/or local funding programmes, which continue to be unstable, and closely associated with political decisions and insufficient institution building. A sharp distinction is made between health and social services, often without regard to client input. The main objective of the paper is to identify the causes of the funding problems currently faced by HR services in the context of their history of institution building which represents a major threat to the future of HR services in the region. METHODS: Qualitative content analysis of documents was conducted in the development of two case studies of the Czech and Slovak Republics. The body of documentation under study comprised policy documents, including National Drug Strategies, Action Plans, ministerial documents, and official budgets and financial schedules, as well as documents from the grey literature and expert opinions. RESULTS: The insufficient investments in finalising the process of the institution building of HR services have resulted in a direct threat to their sustainability. An unbalanced inclination to the institutionalisation of HR within the domain of social services has led to a misperception of their integrity, as well as to their funding and long-term sustainability being endangered. In addition, this tendency has had a negative impact on the process of the institutionalisation of HR within the system of healthcare. CONCLUSION: The case study revealed a lack of systemic grounding of HR services as interdisciplinary health-social services. The aftermath of the financial crisis in 2008 fully revealed the limitations of the funding system established ad hoc in the 1990s, which remains present until today, together with all its weak points. The entire situation is responsible for the dangerous erosion of the interpretation of the concept of harm reduction, which is supported by various stereotypes and false, or ideological, interpretations of the concept.
- 650 _2
- $a poskytování zdravotní péče $7 D003695
- 650 12
- $a snížení rizika poškození $7 D040261
- 650 _2
- $a zdravotnické služby $7 D006296
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a veřejná politika $7 D011640
- 650 12
- $a poruchy spojené s užíváním psychoaktivních látek $7 D019966
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Miklíková, Silvia $u Department of Addictology, First Faculty of Medicine, and General University Hospital in Prague, Charles University, Prague, Czech Republic
- 700 1_
- $a Mravčík, Viktor $u Department of Addictology, First Faculty of Medicine, and General University Hospital in Prague, Charles University, Prague, Czech Republic $u National Monitoring Centre for Drugs and Addiction, Office of the Government of the Czech Republic, Prague, Czech Republic
- 700 1_
- $a Grund, Jean-Paul $u CVO - Addiction Research Centre, Utrecht, The Netherlands
- 700 1_
- $a Černíková, Tereza $u Department of Addictology, First Faculty of Medicine, and General University Hospital in Prague, Charles University, Prague, Czech Republic. cernikova.tereza@vlada.cz $u National Monitoring Centre for Drugs and Addiction, Office of the Government of the Czech Republic, Prague, Czech Republic. cernikova.tereza@vlada.cz
- 773 0_
- $w MED00175640 $t Harm reduction journal $x 1477-7517 $g Roč. 17, č. 1 (2020), s. 83
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33092597 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20220127144930 $b ABA008
- 999 __
- $a ok $b bmc $g 1752128 $s 1155982
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 17 $c 1 $d 83 $e 20201022 $i 1477-7517 $m Harm reduction journal $n Harm Reduct J $x MED00175640
- LZP __
- $a Pubmed-20220113